Original Publication Date: 1 October, 2015
Publication / Source: Hepatic Oncology
Authors: Aliya F Gulamhusein & William Sanchez
Cholangiocarcinoma (CCA) is the second most common primary hepatic neoplasm and accounts for 10–20% of hepatobiliary cancer-related deaths. The prognosis of patients with CCA is poor with 5-year survival rates of 10%, partially due to the limited effective treatment options that exist for this disease. In this review, we discuss the evolving role of liver transplantation in the management of patients with perihilar CCA (pCCA).